Baseline Biomarkers for Outcome of Melanoma Patients Treated with PembrolizumabBenjamin Weide, Jedd D. Wolchok|Clinical Cancer Research|2016Cited by 583
Baseline Peripheral Blood Biomarkers Associated with Clinical Outcome of Advanced Melanoma Patients Treated with IpilimumabAlexander Martens, Benjamin Weide|Clinical Cancer Research|2016Cited by 541
Predictors of responses to immune checkpoint blockade in advanced melanomaNicolas Jacquelot, Laurence Zitvogel, Moshe Sade-Feldman et al.|Nature Communications|2017Cited by 201
Application of Circulating Cell-Free Tumor DNA Profiles for Therapeutic Monitoring and Outcome Prediction in Genetically Heterogeneous Metastatic MelanomaRenáta Váraljai, Alexander Roesch, Kilian Wistuba‐Hamprecht et al.|JCO Precision Oncology|2019Cited by 54
ctDNA as a noninvasive monitoring tool in metastatic melanoma.Renáta Váraljai, Alexander Roesch, Kilian Wistuba‐Hamprecht et al.|Journal of Clinical Oncology|2019Cited by 0